CD8A and neoplasm: Notably, all the 4T1, CT26 and EMT6 tumours were PD-L1 positive (Supplementary Fig. 4c), thus the above data showed our TIOs had a better tumour killing ability than natural CD8+ T cells in terms of breaking through immune checkpoint inhibition.